COURSE DIRECTOR
Ladan Zand, MD

DESCRIPTION
During Renal Biopsy Conference, microscopic slides of interesting biopsy cases from the previous week are interpreted by fellows while teaching points are highlighted by faculty in Pathology and Nephrology/Hypertension.  Case management and patient morbidity are also reviewed.  Every quarter, a video-conference is scheduled with our colleagues at Mayo Clinic Florida to review their cases.  

TARGET AUDIENCE
The audience is primarily the physicians in our division, but all members of the division, i.e. nurses, NP/PAs and allied health staff are encouraged to attend.  We advertise the Grand Rounds title and speaker name throughout the institution which allows other areas/divisions to attend if they wish.  

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Diagnose various kidney diseases based on biopsy findings
• Debate optimal treatment options in the context of biopsy findings
• Distinguish among the different morphologic features of kidney disease by reviewing biopsy specimens with clinicians and renal pathologists

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
Hatem Amer, M.D. - Grant - Kaneka Pharma
Ladan Zand, MD - Consultant - Travere Therapeutics, Inc and Calliditas NA Enterprises, Inc.

All relevant financial relationships listed for these individuals have been mitigated.

No relevant financial relationship(s) with ineligible companies:
Diane Chicos; Mary Fidler, MD; Melissa Hanson; Kathleen Hegna Zelinske; and Jacqlyn Oakland

2024 Speaker Pool

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Kathy Hegna Zelinske at phone 6-1044 OR Jacqlyn Oakland at phone 4-3479

*Required Information for Accreditation is posted in Outlook Calendar Invitation.